Simona Rizzi

845 total citations
9 papers, 180 citations indexed

About

Simona Rizzi is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Simona Rizzi has authored 9 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Neurology. Recurrent topics in Simona Rizzi's work include Neuroblastoma Research and Treatments (3 papers), Cancer therapeutics and mechanisms (2 papers) and HER2/EGFR in Cancer Research (2 papers). Simona Rizzi is often cited by papers focused on Neuroblastoma Research and Treatments (3 papers), Cancer therapeutics and mechanisms (2 papers) and HER2/EGFR in Cancer Research (2 papers). Simona Rizzi collaborates with scholars based in Italy and United States. Simona Rizzi's co-authors include Pier‐Luigi Lollini, Stefania Benini, Katia Scotlandi, Maria Cristina Manara, Massimo Serra, Nicola Baldini, Tokuhiro Chano, Piero Picci, Ulisse Cucchi and Kateryna Krytska and has published in prestigious journals such as Cancer Research, Science Translational Medicine and International Journal of Cancer.

In The Last Decade

Simona Rizzi

9 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simona Rizzi Italy	4	99	71	47	34	31	9	180
Shivani Baisiwala United States	8	145 1.5×	57 0.8×	27 0.6×	12 0.4×	19 0.6×	14	264
Oliver Surriga United States	6	146 1.5×	101 1.4×	49 1.0×	24 0.7×	28 0.9×	10	303
Martina Salzmann Austria	8	99 1.0×	79 1.1×	80 1.7×	12 0.4×	20 0.6×	10	272
David Wasilewski Germany	8	112 1.1×	87 1.2×	81 1.7×	11 0.3×	31 1.0×	26	266
William J. Kaliney United States	7	130 1.3×	149 2.1×	56 1.2×	19 0.6×	12 0.4×	10	296
Marco Vindigni Italy	5	127 1.3×	28 0.4×	21 0.4×	18 0.5×	11 0.4×	13	210
Peter Wurst Germany	6	129 1.3×	61 0.9×	75 1.6×	16 0.5×	12 0.4×	7	226
Jianzhong Lin China	8	158 1.6×	60 0.8×	44 0.9×	15 0.4×	13 0.4×	13	294
Shao Jian Lin China	12	214 2.2×	44 0.6×	31 0.7×	26 0.8×	26 0.8×	14	447
Ehsan Esmaili Shandiz Iran	7	109 1.1×	58 0.8×	43 0.9×	19 0.6×	17 0.5×	11	207

Countries citing papers authored by Simona Rizzi

Since Specialization

Citations

This map shows the geographic impact of Simona Rizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Rizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Rizzi more than expected).

Fields of papers citing papers by Simona Rizzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Rizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Rizzi. The network helps show where Simona Rizzi may publish in the future.

Co-authorship network of co-authors of Simona Rizzi

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Rizzi. A scholar is included among the top collaborators of Simona Rizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Rizzi. Simona Rizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Orsini, Paolo, Simona Rizzi, Ulisse Cucchi, et al.. (2024). Abstract 5805: A novel platform of diversified payloads to drive ADC innovation. Cancer Research. 84(6_Supplement). 5805–5805. 1 indexed citations

2.

Valsasina, Barbara, Paolo Orsini, Michele Caruso, et al.. (2023). Novel Thienoduocarmycin–Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical Studies. Molecular Cancer Therapeutics. 22(12). 1465–1478. 4 indexed citations

3.

Sano, Renata, Kateryna Krytska, Pichai Raman, et al.. (2019). An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma. Science Translational Medicine. 11(483). 45 indexed citations

4.

Sano, Renata, Kateryna Krytska, Gwenda F. Ligon, et al.. (2016). Abstract 2690: A novel antibody-drug conjugate directed to the ALK receptor tyrosine kinase demonstrates efficacy in models of neuroblastoma. Cancer Research. 76(14_Supplement). 2690–2690. 1 indexed citations

5.

Valsasina, Barbara, Fabio Gasparri, Italo Beria, et al.. (2014). Abstract 822: Thienoindoles, a novel class of DNA minor groove alkylating agents highly suited for the generation of novel antibody drug conjugates (ADCs). Cancer Research. 74(19_Supplement). 822–822. 1 indexed citations

6.

Magnaghi, Paola, Roberto D’Alessio, Barbara Valsasina, et al.. (2012). Abstract 2940: Identification of potent VCP/p97/CDC48 inhibitors with distinct biochemical mechanisms including a reversible, allosteric inhibitor that activates the unfolded protein response, induce autophagy and cancer cell death. Cancer Research. 72(8_Supplement). 2940–2940. 1 indexed citations

7.

Cucchi, Ulisse, Laura Gianellini, Francesco Sola, et al.. (2010). Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo.. PubMed. 30(12). 4973–85. 47 indexed citations

8.

Benini, Stefania, Nicola Baldini, Maria Cristina Manara, et al.. (1999). Redundancy of autocrine loops in human osteosarcoma cells. International Journal of Cancer. 80(4). 581–588. 78 indexed citations

9.

Benini, Stefania, Nicola Baldini, Maria Cristina Manara, et al.. (1999). Redundancy of autocrine loops in human osteosarcoma cells. International Journal of Cancer. 80(4). 581–588. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact